Nektar Therapeutics Says Drapeau To Replace Bansal As CFO

SAN CARLOS, Calif.--(BUSINESS WIRE)--Jan. 19, 2006--Nektar Therapeutics (Nasdaq:NKTR) today announced the appointment of Louis Drapeau as Senior Vice President, Finance and Chief Financial Officer. Most recently, Lou held the position of Senior Vice President and Chief Financial Officer of BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) from August 2002 to August 2005. He was also BioMarin's Acting Chief Executive Officer from August 2004 to May 2005. Prior to that, Lou spent over 30 years with Arthur Andersen including 19 years as an Audit Partner in Andersen's Northern California Audit and Business Consulting practice and 12 years as Managing Partner.

Back to news